Etude de l'AG du 27/04/2017
Cette année encore, Proxinvest déplore le fait que la société s’autorise à intervenir sur son capital en période d’offre publique, ce qui peut être considéré comme un outil anti-OPA, et est donc défavorable aux actionnaires.
De plus, Proxinvest regrette particulièrement le manque de transparence de la société concernant, d’une part, la rémunération des dirigeants mandataires sociaux, et d’autre part, les autorisations d’émissions d’options de souscriptions ou d’actions de performance, présentées dans les résolutions 24 à 30.
Notons que le taux de féminisation du Conseil, avec seuleument une femme présente au Conseil, est particulièrement bas (11%), en opposition avec les pratiques de la place et avec les principes de bonne gouvernance.
Carmat is focused on the research and development of an innovative product in the medical sector, developing an orthotopic and biocompatible artificial heart which is completely implantable, as well as its electrical power supply system and remote diagnosis system. Co. is developing a long-term therapeutic solution for patients who suffer from advanced bi-ventricular heart failure and who are not eligible for cardiac transplantation and who have exhausted all drug possibilties. Co. is still in the phase of research and development and thus do not generate any revenues.
Founded in 1995, Proxinvest is an independent proxy firm supporting the engagement and proxy analysis processes of investors. Proxinvest mission is to analyse corporate governance practices and resolutions proposed at general meetings of listed firms.
Proxinvest main services are :
- Proxy reports
- Definition and monitoring of client customized voting guidelines
- Corporate Governance Data and Rating
- Thematic research
- Engagement support
Proxinvest has been a pioneer and champion of good corporate governance and has grown into a recognised expert in the field.
Proxinvest is independently-owned and only works for investors : Proxinvest does not provide consulting services to the companies it covers, mitigating related risks to its clients and ensuring the independence of our analysis. As a result Proxinvest is able to take a robust, independent, engaged and unconflicted view of the companies in which our clients invest.
As Managing Partner of Expert Corprate Governance Service Ltd (ECGS), Proxinvest has built a large network of corporate governance experts to support clients in corporate governance analysis worldwide.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.